Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance.
Department of Microbiology, University of Texas Medical Branch, Galveston 77550.
P
P
Christadoss
M
M
Shenoy
M
M
Oshima
M Z
MZ
Atassi
D000595:Amino Acid Sequence; D000818:Animals; D000831:Animals, Newborn / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D004198:Disease Susceptibility / Q000276:immunology; D005260:Female; D005785:Gene Conversion; D020022:Genetic Predisposition to Disease; D000949:Histocompatibility Antigens Class II / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D007114:Immunization; D016056:Immunodominant Epitopes / Q000276:immunology*; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D009157:Myasthenia Gravis / Q000276:immunology / Q000517:prevention & control*; D010446:Peptide Fragments / Q000008:administration & dosage / Q000276:immunology; D011978:Receptors, Nicotinic / Q000276:immunology*; D016037:Single-Blind Method; D013045:Species Specificity; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*; D014101:Torpedo / Q000276:immunology
D001323:Autoantibodies; D000949:Histocompatibility Antigens Class II; D016056:Immunodominant Epitopes; D010446:Peptide Fragments; D011978:Receptors, Nicotinic